Allstate Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Allstate Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$7.95M	Buy	+110,529	New	+$8.33M	0.24%	57

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Allstate Investment Management's BMY Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2022: 110,529 shares worth $7.95M. The stake represents 0.24% of the portfolio and ranks #57 among its holdings.

2,602 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Allstate Investment Management held 110,529 shares of Bristol-Myers Squibb worth $7.95M as of Q4 2022.
Bristol-Myers Squibb was a new Allstate Investment Management position in Q4 2022.
Bristol-Myers Squibb made up 0.24% of Allstate Investment Management's portfolio in Q4 2022, its #57 holding.
2,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.